Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival

Acta Neuropathologica

Volumn 113, Issue 3, 2007, Pages 325-337

  Lukashova v Zangen, Inna ^a   Kneitz, Susanne ^a   Monoranu, Camelia Maria ^a   Rutkowski, Stefan ^a   Hinkes, Bernward ^a   Vince, Giles Hamilton ^a   Huang, Bei ^a   Roggendorf, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Ependymoma; Ki 67; Microarray analysis; Overall survival; Subependymoma

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 4; EPHRIN RECEPTOR B3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; ONCOPROTEIN; PROTEIN BNIP3; PROTEIN CCNA1; PROTEIN COL4A2; PROTEIN EBP; PROTEIN GLIS3; PROTEIN MRC1; PROTEIN NRCAM; PROTEIN TIA1; PROTEIN TOP2A; PROTEIN UFD1L; PROTEIN YWHAE; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; DNA MICROARRAY; EPENDYMOMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; INTRACRANIAL TUMOR; MALE; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD TUMOR; TUMOR LOCALIZATION;

EID: 33947393501     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0190-5     Document Type: Article

References (54)

1. Alonso ME, Bello MJ, Arjona D, Gonzalez-Gomez P, Lomas J, de Campos JM, Kusak ME, Isla A, Rey JA (2002) Analysis of the NF2 gene in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 134:1-5
2. Alterman RL, Stanley ER (1994) Colony stimulating factor-1 expression in human glioma. Mol Chem Neuropathol 21:177-188
3. Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP (2005) Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Genes Chromosomes Cancer 43:329-338
4. Andersson A, Olofsson T, Lindgren D, Nilsson B, Ritz C, Eden P, Lassen C, Rade J, Fontes M, Morse H, Heldrup J, Behrendtz M, Mitelman F, Hoglund M, Johansson B, Fioretos T (2005) Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proc Natl Acad Sci USA 102:19069-19074
5. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison DW (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86:929-939
6. Collins VP (1995) Gene amplification in human gliomas. Glia 15:289-296
7. Doege H, Bocianski A, Scheepers A, Axer H, Eckel J, Joost HG, Schurmann A (2001) Characterization of human glucose transporter (GLUT) 11 (encoded by SLC2A11), a novel sugar-transport facilitator specifically expressed in heart and skeletal muscle. Biochem J 359:443-449
8. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161:2133-2141
9. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A (1999) Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155:627-632
10. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M, Pellissier JF (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93:605-613
11. Goldberg JL, Vargas ME, Wang JT, Mandemakers W, Oster SF, Sretavan DW, Barres BA (2004) An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells. J Neurosci 24:4989-4999
12. Grunblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, Li J, Ravid R, Roggendorf W, Riederer P, Youdim MB (2004) Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111:1543-1573
13. Hinek A, Jung S, Rutka JT (1999) Cell surface aggregation of elastin receptor molecules caused by suramin amplified signals leading to proliferation of human glioma cells. Acta Neuropathol 97:399-407
14. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158:1137-1143
15. Ho DM, Hsu CY, Wong TT, Chiang H (2001) A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma. J Neurooncol 54:77-85
16. Homma J, Yamanaka R, Yajima N, Tsuchiya N, Genkai N, Sano M, Tanaka R (2006) Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients. Oncol Rep 15:595-601
17. Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W (2002) Loss of heterozygosity on chromosome 22 in human ependymomas. Acta Neuropathol 103:415-420
18. Huang B, Starostik P, Schraut H, Krauss J, Sorensen N, Roggendorf W (2003) Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Acta Neuropathol 106:357-362
19. Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 27:371-377
20. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1):96-104
21. Jaing TH, Wang HS, Tsay PK, Tseng CK, Jung SM, Lin KL, Lui TN (2004) Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas. J Neurooncol 68:255-261
22. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S (2005) Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24:980-991
23. Konishi H, Nakagawa T, Harano T, Mizuno K, Saito H, Masuda A, Matsuda H, Osada H, Takahashi T (2002) Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers. Cancer Res 62:271-276
24. Korshunov A, Golanov A, Sycheva R, Timirgaz V (2004) The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients. Cancer 100:1230-1237
25. Korshunov A, Neben K, Wrobel G, Tews B, Benner A, Hahn M, Golanov A, Lichter P (2003) Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age. Am J Pathol 163:1721-1727
26. Kurt E, Zheng PP, Hop WC, van der Weiden M, Bol M, van den Bent MJ, Avezaat CJ, Kros JM (2006) Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Cancer 106:388-395
27. Lannon CL, Sorensen PH (2005) ETV6-NTRK3: A chimeric protein tyrosine kinase with transformation activity in multiple cell lineages. Semin Cancer Biol 15:215-223
28. Lin SY, Li K, Stewart GS, Elledge SJ (2004) Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation. Proc Natl Acad Sci USA 101:6484-6489
29. Monoranu CM, Kochs D, Huang B, Loukachova-v.Zangen I, Roggendorf W (2004) Ependymomas in adults: LOH analysis, MIB1 labeling and EMA expression and correlation with clinical data. Acta Neuropathol 108:356
30. Naidoo V, Naidoo S, Mahabeer R, Raidoo DM (2005) Localization of the endothelin system in human diffuse astrocytomas. Cancer 104:1049-1057
31. Oster SF, Bodeker MO, He F, Sretavan DW (2003) Invariant Sema5A inhibition serves an ensheathing function during optic nerve development. Development 130:775-784
32. Ragazzini P, Gamberi G, Pazzaglia L, Serra M, Magagnoli G, Ponticelli F, Ferrari C, Ghinelli C, Alberghini M, Bertoni F, Picci P, Benassi MS (2004) Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. Histol Histopathol 19:401-411
33. Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A (2005) Alterations of protein 4.1 family members in ependymomas: A study of 84 cases. Mod Pathol 18:991-997
34. Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230-237
35. Reni M, Brandes AA, Vavassori V, Cavallo G, Casagrande F, Vastola F, Magli A, Franzin A, Basso U, Villa E (2004) A multicenter study of the prognosis and treatment of adult brain ependymal tumors. Cancer 100:1221-1229
36. Rickert CH (2004) Prognosis-related molecular markers in pediatric central nervous system tumors. J Neuropathol Exp Neurol 63:1211-1224
37. Schiffer D, Giordana MT (1998) Prognosis of ependymoma. Childs Nerv Syst 14:357-361
38. Sehgal A, Boynton AL, Young RF, Vermeulen SS, Yonemura KS, Kohler EP, Aldape HC, Simrell CR, Murphy GP (1998) Cell adhesion molecule Nr-CAM is over-expressed in human brain tumors. Int J Cancer 76:451-458
39. Sehgal A, Ricks S, Warrick J, Boynton AL, Murphy GP (1999) Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells. Anticancer Res 19:4947-4953
40. Shuangshoti S, Rushing EJ, Mena H, Olsen C, Sandberg GD (2005) Supratentorial extraventricular ependymal neoplasms: A clinicopathologic study of 32 patients. Cancer 103:2598-2605
41. Smyth GK (2005) Limma: Linear models for microarray data. In: Gentleman R (ed) Bioinformatics and computational biology solutions using R and bioconductor. Springer, New York, pp 397-420
42. Smyth GK, Yang YH, Speed T (2003) Statistical issues in cDNA microarray data analysis, Methods Mol Biol 224:111-136
43. Stettner G, Klein R, Roggendorf W (1999) HLA-DR expression in microglia and tumor cells of childhood ependymomas: An immunhistochemical study. Acta Neuropathol 98:552
44. Suarez-Merino B, Hubank M, Revesz T, Harkness W, Hayward R, Thompson D, Darling JL, Thomas DG, Warr TJ (2005) Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3. Neuro-oncol 7:20-31
45. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323-335
46. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99:6567-6572
47. Timmermann B, Kortmann RD, Kuhl J, Meisner C, Slavc I, Pietsch T, Bamberg M (2000) Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: Results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys 46:287-295
48. Timmermann B, Kortmann RD, Kuhl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M (2005) Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: Results of the prospective German brain tumor trials HIT-SKK 87 and 92. Radiother Oncol 77:278-285
49. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM (2003) Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 163:1033-1043
50. Velazquez-Fernandez D, Laurell C, Geli J, Hoog A, Odeberg J, Kjellman M, Lundeberg J, Hamberger B, Nilsson P, Backdahl M (2005) Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy. Surgery 138:1087-1094
51. Verstegen MJ, Leenstra DT, Ijlst-Keizers H, Bosch DA (2002) Proliferation- and apoptosis-related proteins in intracranial ependymomas: An immunohistochemical analysis. J Neurooncol 56:21-28
52. Wiestler OD, Schiffer D, Coons SW, Prayson RA, Rosenblum MK (2000) Ependymoma. In: Kleihues P (ed) Pathology and genetics of tumors the nervous system. IARC Press, Lyon, pp 71-82
53. Wolfsberger S, Fischer I, Hoftberger R, Birner P, Slavc I, Dieckmann K, Czech T, Budka H, Hainfellner J (2004) Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma. Am J Surg Pathol 28:914-920
54. Yu J, Zhang H, Gu J, Lin S, Li J, Lu W, Wang Y, Zhu J (2004) Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer 4:65